-
1
-
-
0030515971
-
Expression of estrogen and progesterone receptors in non-small-cell lung cancer: Immunohistochemical study
-
Su JM, Hsu HK, Chang H, et al. (1996) Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study. Anticancer Res 16(6B):3803-6.
-
(1996)
Anticancer Res
, vol.16
, Issue.6 B
, pp. 3803-3806
-
-
Su, J.M.1
Hsu, H.K.2
Chang, H.3
-
2
-
-
0037169815
-
Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue
-
Fasco MJ, Hurteau GJ, Spivack SD (2002) Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue. Mol Cell Endocrinol 188(1-2):125-40.
-
(2002)
Mol Cell Endocrinol
, vol.188
, Issue.1-2
, pp. 125-140
-
-
Fasco, M.J.1
Hurteau, G.J.2
Spivack, S.D.3
-
3
-
-
0036532167
-
Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen
-
Stabile LP, Davis AL, Gubish CT, et al. (2002) Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res 62(7):2141-50.
-
(2002)
Cancer Res
, vol.62
, Issue.7
, pp. 2141-2150
-
-
Stabile, L.P.1
Davis, A.L.2
Gubish, C.T.3
-
4
-
-
28444449009
-
Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer
-
Kawai H, Ishii A, Washiya K, et al. (2005) Combined overexpression of EGFR and estrogen receptor alpha correlates with a poor outcome in lung cancer. Anticancer Res 25(6C):4693-8.
-
(2005)
Anticancer Res
, vol.25
, Issue.6 C
, pp. 4693-4698
-
-
Kawai, H.1
Ishii, A.2
Washiya, K.3
-
5
-
-
22344449903
-
Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer
-
Kawai H, Ishii A, Washiya K, et al. (2005) Estrogen receptor alpha and beta are prognostic factors in non-small cell lung cancer. Clin Cancer Res 11(14):5084-9.
-
(2005)
Clin Cancer Res
, vol.11
, Issue.14
, pp. 5084-5089
-
-
Kawai, H.1
Ishii, A.2
Washiya, K.3
-
6
-
-
27144527294
-
Nuclear estrogen receptor beta in lung cancer: Expression and survival differences by sex
-
Schwartz AG, Prysak GM, Murphy V, et al. (2005) Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res 11(20):7280-7.
-
(2005)
Clin Cancer Res
, vol.11
, Issue.20
, pp. 7280-7287
-
-
Schwartz, A.G.1
Prysak, G.M.2
Murphy, V.3
-
7
-
-
0021140954
-
Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels
-
Fitzpatrick SL, Brightwell J, Wittliff JL, et al. (1984) Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 44(8):3448-53.
-
(1984)
Cancer Res
, vol.44
, Issue.8
, pp. 3448-3453
-
-
Fitzpatrick, S.L.1
Brightwell, J.2
Wittliff, J.L.3
-
8
-
-
0024950999
-
Characteristics and distribution of receptors for [DTRP6]- luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer
-
Fekete M, Wittliff JL, Schally AV (1989) Characteristics and distribution of receptors for [DTRP6]- luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer. J Clin Lab Anal 3(3):137-47.
-
(1989)
J Clin Lab Anal
, vol.3
, Issue.3
, pp. 137-147
-
-
Fekete, M.1
Wittliff, J.L.2
Schally, A.V.3
-
9
-
-
0242721012
-
The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro
-
Gee JM, Harper ME, Hutcheson IR, et al. (2003) The antiepidermal growth factor receptor agent gefitinib (ZD1839/Iressa) improves antihormone response and prevents development of resistance in breast cancer in vitro. Endocrinology 144(11):5105-17.
-
(2003)
Endocrinology
, vol.144
, Issue.11
, pp. 5105-5117
-
-
Gee, J.M.1
Harper, M.E.2
Hutcheson, I.R.3
-
10
-
-
0041736202
-
Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells
-
Hutcheson IR, Knowlden JM, Madden TA, et al. (2003) Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells. Breast Cancer Res Treat 81(1):81-93.
-
(2003)
Breast Cancer Res Treat
, vol.81
, Issue.1
, pp. 81-93
-
-
Hutcheson, I.R.1
Knowlden, J.M.2
Madden, T.A.3
-
11
-
-
0037338707
-
Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor
-
Levin ER (2003) Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17(3):309-17.
-
(2003)
Mol Endocrinol
, vol.17
, Issue.3
, pp. 309-317
-
-
Levin, E.R.1
-
12
-
-
18044379750
-
Growth factor signalling networks in breast cancer and resistance to endocrine agents: New therapeutic strategies
-
Nicholson RI, Hutcheson IR, Britton D, et al. (2005) Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies. J Steroid Biochem Mol Biol 93(2-5):257-62.
-
(2005)
J Steroid Biochem Mol Biol
, vol.93
, Issue.2-5
, pp. 257-262
-
-
Nicholson, R.I.1
Hutcheson, I.R.2
Britton, D.3
-
13
-
-
0019762143
-
Methods of steroid receptor analyses and their quality control in the clinical laboratory
-
Wittliff JL, Durant JR, Fisher B (1981) Methods of steroid receptor analyses and their quality control in the clinical laboratory. Prog Clin Biol Res 74:397-411.
-
(1981)
Prog Clin Biol Res
, vol.74
, pp. 397-411
-
-
Wittliff, J.L.1
Durant, J.R.2
Fisher, B.3
-
15
-
-
0036403538
-
Laser capture microdissection and its applications in genomics and proteomics
-
Wittliff JL, Erlander MG (2002) Laser capture microdissection and its applications in genomics and proteomics. Methods Enzymol 356:12-25.
-
(2002)
Methods Enzymol
, vol.356
, pp. 12-25
-
-
Wittliff, J.L.1
Erlander, M.G.2
|